BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26098457)

  • 1. Incidence of Internal Mammary Lymph Nodes with Silicone Breast Implants at MR Imaging after Oncoplastic Surgery.
    Sutton EJ; Watson EJ; Gibbons G; Goldman DA; Moskowitz CS; Jochelson MS; Dershaw DD; Morris EA
    Radiology; 2015 Nov; 277(2):381-7. PubMed ID: 26098457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of benign and malignant peri-implant fluid collections and masses on magnetic resonance imaging in women with silicone implants.
    Sutton EJ; Dashevsky BZ; Watson EJ; Tyagi N; Bernard-Davila B; Martinez D; Dogan A; Horwitz SM; Cordeiro PG; Morris EA
    Cancer Med; 2020 May; 9(10):3261-3267. PubMed ID: 31568670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of internal mammary lymph node (IMLN) biopsy during autologous reconstruction in breast cancer patients.
    Zhang X; Jaffer S; Bleiweiss IJ; Nayak A
    Breast Cancer Res Treat; 2015 Oct; 153(3):565-72. PubMed ID: 26358711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorodeoxyglucose--positive internal mammary lymph node in breast cancer patients with silicone implants: is it always metastatic cancer?
    Soudack M; Yelin A; Simansky D; Ben-Nun A
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):79-82. PubMed ID: 23299238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramammary lymph nodes: patterns of discovery and clinical significance.
    Vijan SS; Hamilton S; Chen B; Reynolds C; Boughey JC; Degnim AC
    Surgery; 2009 May; 145(5):495-9. PubMed ID: 19375607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Presence of intramammary lymph nodes in the preoperative lymphoscintigraphy to locate the sentinel lymph node. Clinical significance].
    Nogareda Z; Álvarez A; Perlaza P; Caparrós FX; Alonso I; Paredes P; Vidal-Sicart S
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):83-8. PubMed ID: 25434980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
    Nakajima N; Kataoka M; Sugawara Y; Ochi T; Kiyoto S; Ohsumi S; Mochizuki T
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):738-46. PubMed ID: 24064322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramammary lymph nodes and breast cancer: a marker for disease severity, or just another lymph node?
    Guth AA; Mercado C; Roses DF; Hiotis K; Skinner K; Diflo T; Cangiarella J
    Am J Surg; 2006 Oct; 192(4):502-5. PubMed ID: 16978960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
    Hahn S; Hecktor J; Grabellus F; Hartung V; Pöppel T; Kimmig R; Forsting M; Antoch G; Heusner TA
    Acta Radiol; 2012 Jun; 53(5):518-23. PubMed ID: 22547387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
    Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Ozonoff A; Miller JP; Kalinyak JE
    Radiology; 2011 Jan; 258(1):59-72. PubMed ID: 21076089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of internal mammary lymph node metastases found incidentally during free flap recipient vessel exposure.
    Schaverien MV; Purdie CA; Munnoch DA
    Eur J Surg Oncol; 2013 Jun; 39(6):608-12. PubMed ID: 23562362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Metastatic Rate of Internal Mammary Lymph Nodes When Metastasis of Internal Mammary Lymph Node Is Suspected on PET/CT.
    Choi JE
    J Breast Cancer; 2013 Jun; 16(2):202-7. PubMed ID: 23843854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients.
    Ohsumi S; Inoue T; Kiyoto S; Hara F; Takahashi M; Takabatake D; Takashima S; Aogi K; Takashima S
    Breast Cancer Res Treat; 2011 Nov; 130(1):267-72. PubMed ID: 21590272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
    Hathaway PB; Mankoff DA; Maravilla KR; Austin-Seymour MM; Ellis GK; Gralow JR; Cortese AA; Hayes CE; Moe RE
    Radiology; 1999 Mar; 210(3):807-14. PubMed ID: 10207485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
    Fuster D; Duch J; Paredes P; Velasco M; Muñoz M; Santamaría G; Fontanillas M; Pons F
    J Clin Oncol; 2008 Oct; 26(29):4746-51. PubMed ID: 18695254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
    Plaza MJ; Collado-Mesa F; Bokhoor J; Alperin N; Yepes MM
    Breast J; 2014; 20(3):235-42. PubMed ID: 24750508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
    Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
    J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
    Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H
    Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary lymph node characterization in breast cancer patients using magnetic resonance mammography: a prospective comparative study with FDG PET-CT and healthy women.
    Krammer J; Wasser K; Schnitzer A; Henzler T; Schoenberg SO; Kaiser CG
    Eur J Radiol; 2013 Dec; 82(12):2194-8. PubMed ID: 23993142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.